Stay updated on Pembrolizumab and Radiotherapy in Liver Cancer Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab and Radiotherapy in Liver Cancer Clinical Trial page.

Latest updates to the Pembrolizumab and Radiotherapy in Liver Cancer Clinical Trial page
- Check2 days agoChange DetectedThe page revision label was updated from v3.6.2 to v3.6.3, indicating a newer version of the page rendering. This is a technical version bump and does not modify the clinical study content or data.SummaryDifference0.1%

- Check9 days agoChange DetectedThe page now shows Revision: v3.6.2 replacing the previous v3.6.0, indicating a minor version update rather than a substantive change to trial information.SummaryDifference0.1%

- Check16 days agoNo Change Detected
- Check24 days agoChange DetectedThe page now displays 'No longer looking for participants,' indicating that this study has halted enrollment and will not recruit new participants. This aligns with the study's terminated status.SummaryDifference0.6%

- Check31 days agoChange DetectedA revision line was added showing Revision: v3.5.5, and the previous Revision: v3.5.4 line was removed.SummaryDifference0.1%

- Check52 days agoChange DetectedThe page now shows Revision: v3.5.4, representing an updated version of the page. The study details and displayed information remain unchanged.SummaryDifference0.1%

- Check59 days agoChange DetectedRevision label on the study record was updated from v3.5.2 to v3.5.3, indicating a minor metadata update. It does not alter the study data or visible content on the page.SummaryDifference0.1%

Stay in the know with updates to Pembrolizumab and Radiotherapy in Liver Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab and Radiotherapy in Liver Cancer Clinical Trial page.